ArticleFrontiers in oncology2026

Real-world efficacy and safety of golidocitinib in 3 patients with relapsed/refractory peripheral T-cell lymphoma.

Bianhong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.